Evonik Acquires Biomaterials Company JeNaCell

Evonik announced today that it has acquired German biotech company JeNaCell, expanding its biomaterials portfolio with the startup’s biotechnologically derived cellulose. JeNaCell’s biomaterial is used in medical procedures involving wounds and burns as well as in hydro-active skincare treatments.

Evonik first invested in JeNaCell in 2015 through its venture capital arm. With this acquisition, JeNaCell’s portfolio will be integrated into Evonik’s healthcare business, which is shifting from a nutrition and care focus toward system solutions and an expanded division-wide technology platform of natural materials for medical technology. Evonik plans to increase the share of system solutions in its Nutrition & Care division from the current 20% to more than 50% by 2030 … read more

Newsletter Signup

Subscribe to our weekly newsletter below for an update of everything from the week